P521: TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PEDIATRIC PATIENTS WITH TAGRAXOFUSP, A CD123-TARGETED THERAPY

• N. Pemmaraju,
• B. Cuglievan,
• J. Lasky,
• A. Kheradpour,
• N. Hijiya,
• A. S. Stein,
• S. Meshinchi,
• C. Mullen,
• E. Angelucci,
• L. Vinti,
• T. I. Mughal,
• A. Pawlowska

Affiliations

N. Pemmaraju

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

B. Cuglievan

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

J. Lasky

2 Cure 4 The Kids Foundation, Las Vegas

A. Kheradpour

3 Department of Pediatric Hematology and Oncology, Loma Linda University Children Hospital, Loma Linda

N. Hijiya

4 Division of Pediatric Oncology, Hematology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York

A. S. Stein

5 Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte

S. Meshinchi

6 Department of Pediatrics, University of Washington School of Medicine, Seattle

C. Mullen

7 Division of Pediatric Hematology/Oncology, Department of Pediatrics, Golisano Children’s Hospital, University of Rochester, Rochester, United States of America

E. Angelucci

8 Hematology and cellular therapy unit, IRCCS Ospedale Policlinico San Martino, Genova

L. Vinti

9 Department of Paediatric Haematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

T. I. Mughal

10 Division of Hematology-Oncology, Tufts University Medical School, Boston

A. Pawlowska

12 Department of Pediatrics, City of Hope National Medical Center, Duarte, United States of America